Performance of PFE Pfizer | -15.6% in 12m

Compare PFE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Pfizer with its related Sector/Index XLV

Compare Pfizer with its related Sector/Index XLV

Performance Duell PFE vs XLV

TimeFrame PFE XLV
1 Day 0.88% 0.51%
1 Week 3.63% -0.27%
1 Month 8.04% 1.40%
3 Months 17.0% 6.84%
6 Months 9.19% 6.83%
12 Months -15.6% 10.54%
YTD 3.87% 7.35%
Rel. Perf. 1m 0.67
Rel. Perf. 3m 1.02
Rel. Perf. 6m 0.12
Rel. Perf. 12m 0.12

Is Pfizer a good stock to buy?

Probably not. Based on ValueRay Fundamental Analyses, Pfizer (NYSE:PFE) is currently (July 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -26.01 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PFE as of July 2024 is 28.67. This means that PFE is currently overvalued and has a potential downside of -4.34% (Sold with Premium).

Is PFE a buy, sell or hold?

  • Strong Buy: 7
  • Buy: 2
  • Hold: 16
  • Sell: 0
  • Strong Sell: 0
Pfizer has received a consensus analysts rating of 3.64. Therefor, it is recommend to hold PFE.
Values above 0%: PFE is performing better - Values below 0%: PFE is underperforming

Compare PFE with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 5.59% 7.35% -5.33% -38.20%
US NASDAQ 100 QQQ 7.59% 9.18% -3.97% -42.83%
US Dow Jones Industrial 30 DIA 2.92% 4.99% 1.83% -31.54%
German DAX 40 DBXD 6.80% 7.55% -0.07% -25.34%
UK FTSE 100 ISFU 5.41% 7.02% -4.19% -25.69%
Shanghai Shenzhen CSI 300 CSI 300 1.96% 6.11% 1.72% -7.20%
Hongkong Hang Seng HSI 5.96% 9.44% 8.71% 0.10%
Japan Nikkei 225 EXX7 7.84% 6.14% 5.70% -24.13%
India NIFTY 50 INDA 5.19% 5.80% -4.10% -41.80%
Brasil Bovespa EWZ 7.58% 4.87% 21.43% -4.54%

PFE Pfizer vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 5.02% 6.92% -5.16% -46.56%
Consumer Discretionary XLY 5.55% 4.10% 1.34% -25.63%
Consumer Staples XLP 2.80% 6.66% -0.82% -21.54%
Energy XLE 1.59% 4.89% -7.89% -27.09%
Financial XLF 2.52% 4.35% -4.65% -38.08%
Health Care XLV 3.90% 6.64% 2.36% -26.18%
Industrial XLI 3.07% 6.36% -2.58% -31.20%
Materials XLB 4.06% 7.03% -1.31% -25.08%
Real Estate XLRE 2.33% 1.42% 2.73% -23.34%
Technology XLK 9.16% 11.34% -1.53% -41.79%
Utilities XLU 5.22% 6.76% -7.70% -21.87%
Aerospace & Defense XAR 3.66% 5.66% -1.96% -33.80%
Biotech XBI 5.10% -0.57% -2.97% -32.69%
Homebuilder XHB 0.39% -0.77% -8.31% -52.01%
Retail XRT 5.60% 7.80% -1.64% -31.03%

PFE Pfizer vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 6.43% 9.82% -4.15% -25.98%
Natural Gas UNG 11.37% 32.90% 40.44% 34.98%
Gold GLD 4.25% 6.40% -8.80% -37.87%
Silver SLV 8.72% 12.72% -19.93% -35.17%
Copper CPER 10.44% 14.02% -2.63% -26.75%

Returns of PFE vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 4.72% 8.83% 8.46% -10.91%
iShares High Yield Corp. Bond HYG 3.63% 6.63% 4.96% -25.74%
Does Pfizer outperform its market, is PFE a Sector Leader?
No, over the last 12 months Pfizer (PFE) made -15.64%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 10.54%.
Over the last 3 months PFE made 17.01%, while XLV made 6.84%.
Period PFE XLV S&P 500
1 Month 8.04% 1.40% 0.69%
3 Months 17.01% 6.84% 11.23%
12 Months -15.64% 10.54% 22.56%